(Q50112634)

25 February 2018

title

Mucosal and systemic HIV-1 Env-specific CD8(+) T-cells develop after intragastric vaccination with a Salmonella Env DNA vaccine vector. (English)

1 reference

25 February 2018

author name string

Shata MT

1

1 reference

25 February 2018

Reitz MS Jr

2

1 reference

25 February 2018

DeVico AL

3

1 reference

25 February 2018

Lewis GK

4

1 reference

25 February 2018

Hone DM

5

1 reference

25 February 2018

language of work or name

English

0 references

publication date

1 November 2001

1 reference

25 February 2018

published in

Vaccine

1 reference

25 February 2018

volume

20

1 reference

25 February 2018

page(s)

623-629

1 reference

25 February 2018

issue

3-4

1 reference

25 February 2018

Protection against vaginal SIV transmission with microencapsulated vaccine

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900330-9

7 January 2021

Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900330-9

7 January 2021

Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900330-9

7 January 2021

HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900330-9

7 January 2021

Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900330-9

7 January 2021

CD8+ T lymphocyte control of HIV replication in cultured CD4+ cells varies among infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900330-9

7 January 2021

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900330-9

7 January 2021

Suppression of HIV replication by CD8+ cell clones derived from HIV-infected and uninfected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900330-9

7 January 2021

Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900330-9

7 January 2021

Effective induction of HIV-specific CTL by multi-epitope using gene gun in a combined vaccination regime

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900330-9

7 January 2021

Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900330-9

7 January 2021

Induction of mucosal and systemic responses against human immunodeficiency virus type 1 glycoprotein 120 in mice after oral immunization with a single dose of a Salmonella-HIV vector

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900330-9

7 January 2021

Highly attenuated HIV type 2 recombinant poxviruses, but not HIV-2 recombinant Salmonella vaccines, induce long-lasting protection in rhesus macaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900330-9

7 January 2021

Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900330-9

7 January 2021

Oral somatic transgene vaccination using attenuated S. typhimurium.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900330-9

7 January 2021

An autologous oral DNA vaccine protects against murine melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900330-9

7 January 2021

Molecular cloning and characterization of the HTLV-III virus associated with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900330-9

7 January 2021

Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900330-9

7 January 2021

Construction of genetically defined double aro mutants of Salmonella typhi

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900330-9

7 January 2021

Codon usage limitation in the expression of HIV-1 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900330-9

7 January 2021

Automated DNA sequencing: ultrasensitive detection of fluorescent bands during electrophoresis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900330-9

7 January 2021

Direct gene transfer into mouse muscle in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900330-9

7 January 2021

Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900330-9

7 January 2021

An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900330-9

7 January 2021

Enumeration of IFN-gamma-producing human lymphocytes by spot-ELISA. A method to detect lymphokine-producing lymphocytes at the single-cell level

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900330-9

7 January 2021

Quantification of antigen specific CD8+ T cells using an ELISPOT assay.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900330-9

7 January 2021

Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900330-9

7 January 2021

Construction and characterization of a Salmonella typhi-based human immunodeficiency virus type 1 vector vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900330-9

7 January 2021

Pre-clinical development of a multi-CTL epitope-based DNA prime MVA boost vaccine for AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900330-9

7 January 2021

10.1016/S0264-410X(01)00330-9

Identifiers

DOI

1 reference

25 February 2018

PubMed ID

11672930

1 reference

25 February 2018